FIGS, Inc. (FIGS): Results of Operations and Financial Condition
FIGS, Inc. (FIGS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 figs-q22026xearningsreleas.htm EX-99.1 Document FIGS Releases Second Quarter 2026 Financial Results Exceeded Top and Bottom Line Expectations Grew Net Revenues 28.8% Achieved Net Income Margin of 14.4% and Adjusted EBITDA Margin of 18.6% Increasing Share Repurchase Auth
How this was made
The 30-second read
Why it matters
The filing provides new, decision-relevant inputs: Q2 revenue and margin performance, net income improvement, and a specific full-year outlook range, plus a $100M increase to the repurchase program. The tariff-refund impact is explicitly called out, which may affect how investors model normalized margins.
Market read
Traders can update models immediately using the disclosed Q2 metrics, the stated full-year targets, and the incremental capital return authorization.
What to watch
Operating expenses rose 21.9% YoY in absolute terms; traders may watch whether expense leverage persists beyond the quarter and whether international growth remains profitable.
Background
This is FIGS’ SEC 8-K (Item 2.02) releasing Q2 2026 financial results and providing full-year 2026 outlook, including a board-approved increase to its share repurchase authorization.
Ticker impact
FIGS reported Q2 2026 results with net revenues up 28.8% and raised its full-year 2026 outlook, plus a $100M share repurchase authorization.
Likely positive bias for FIGS shares into/after the earnings call, with follow-through dependent on whether investors focus on tariff-refund effects versus underlying margin expansion.
The filing includes specific Q2 financial results (revenue, net income, adjusted EBITDA and margins) and a stated full-year outlook range, plus a board-approved $100M increase to the repurchase program.
Market effects
Healthcare apparel retailers and direct-to-consumer apparel names may see read-across on margin durability and demand strength.
International revenue growth (up 67% YoY) highlights potential non-US demand momentum.
Tariff-related refund accounting (IEEPA) may keep investors focused on policy-driven gross margin volatility across apparel supply chains.
Counterpoint
Margin strength may be partially influenced by IEEPA tariff refunds; investors could discount the sustainability of gross margin and adjusted EBITDA if refunds normalize.
Key entities
- issuerFIGS, Inc.
Healthcare apparel brand reporting Q2 2026 results, margin drivers, and full-year 2026 outlook, with an increased share repurchase authorization.
- executiveTrina Spear
CEO and co-founder quoted on broad-based performance and outlook.
- executiveSarah Oughtred
CFO quoted on adjusted EBITDA margin drivers and the rationale for the increased buyback.
